Neurobiology of depression;Neurobiología de la depresión

Anales del Sistema Sanitario de Navarra

Volumn 25, Issue SUPPL. 3, 2002, Pages 43-62

  Zandio, M ^a   Ferrin M ^a   Hill, M J ^a   Costs, Manuel J ^a  

^a Unit of Psychiatry   (Spain)

Author keywords

Depression; Mood disorders; Neurobiology; Neuronal plasticity; Neurotransmitters

Indexed keywords

ARTICLE; CELL SURVIVAL; CLINICAL FEATURE; DEPRESSION; ENDOCRINE SYSTEM; EXTRACELLULAR MATRIX; GENETIC ANALYSIS; IMMUNE SYSTEM; MODULATION; NERVE CELL PLASTICITY; NEUROANATOMY; NEUROBIOLOGY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0036968605     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. MANJI HK, LENOX HR. Signaling: Cellular insights into pathophysiology of bipolar disorder. Biol Psychiatry 2000; 48: 518-527.
2. BURMEISTER, M. Basic concepts in the study of diseases with complex genetics. Biol Psychiatry 1999; 45: 522-532.
3. DUMAN RS, HENINGER GR, NESTLER EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
4. ALTAR CA. Neurotrophins and depression. Trends Pharmacol Sci 1999; 20: 59-61.
5. DREVETS WC. Neuroimaging Studies of Mood Disorders. Biol Psychiatry 2000; 48: 813-829.
6. STARKSTEIN SE, ROBINSON RG. Depression in cerebrovascular disease. Depression in neurologic disease. The Johns Hopkins University Press. 1993
7. THOMAS AJ, FERRIER IN, KALARIA NH, PERRY RH, BROWN A, O'BRIEN JT. A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry 2001; 70: 83-87.
8. FUJIKAMA T, YANAI I, YAMAWAKI S. Psychosocial stressors in patients with mayor depression and silent cerebral infarction. Stroke 1997; 28: 1123-1125.
9. STARKSTEIN SE, ROBINSON RG, BERTHIER ML, PRICE TR. Depressive disorders following posterior circulation compared with middle cerebral artery infarcts. Brain 1988; 111: 375-387.
10. STEFFENS DC, KRISHNAN KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705-712.
11. DAMASIO AR, TRANEL D, DAMASIO H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res 1990; 41: 81-94.
12. FRYSTAZTAK RJ, NEAFSEY EJ. The effect of medial frontal cortex lessions on cardiovascular conditioned emotional reponses in the rat. Brain Res 1994; 43:181-193.
13. MORGAN MA, LEDOUX JE. Differential contribution of dorsal and ventral medial prefrontal cortex to acquisition and extinction of conditioned fear in rats. Behav Neurosci 1995; 109: 681-688.
14. SULLIVAN RM, GRATTON A. Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress reponses in rats. J Neurosci 1999; 19: 2834-2840.
15. CARMICHAEL ST, PRICE JL. Limbic connections of the orbital and medial prefrontal cortex in Macaque monkeys. J Comp Neurol 1995; 363: 615-641.
16. LEUCHNETZ GR, ASTRUC J. The efferent projections of the medial prefrontal cortex in the squirrel monkey (Saimiri sciureus). Brain Res 1976; 109: 455-472.
17. SCHULTZ W. Dopamine neurons and the role in reward mechanisms. Curr Opin Neurobiol 1997; 7: 191-197.
18. PRICE JL, CARMICHAEL ST, DREVETS WC. Networks related to the orbital and medial prefrontal cortex: A substrate for emotional behavior? En: Holstege G; Bandler R, Saper CB, editors. Progress in the Brain Research: The Emotional Motor System 1996; 107: 523-536.
19. BECHARA A, DAMASIO H, TRANEL D, ANDERSON SW. Dissociation of working memory from decision-making within the human prefrontal cortex. J Neurosci 1998; 18: 428-437.
20. ROLLS ET. A theory emotion and consciousness, and its application to understanding the neuronal basis of emotion. En: Gazzaniga MS, editor. The Cognitive Neurosciences. Cambridge, MA: MIT Press, 1995; 1091-1106.
21. DINAN TG. Psyconeuroendocrinology of mood disorders. Curr Opin Psychiatry 2001; 14: 51-55.
22. CHIMOWITZ MI, ESTES ML, FURLAN AJ, AWAD IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49: 747-752.
23. DREVETS WC, GADDE K, KRISHNAN R. Neuroimaging studies of depression. En: Charney DS, Nestler EJ, Bunney BJ, Edit. Neurobiology of Mental Illness. New York: Oxford University Press, 1999b; 394-418.
24. FAZEKAS F. Magnetic resonance signal abnormalities in asymptomatic individuals: Their incidence and functional correlates. Eur Neurol 1989; 29: 164-168.
25. WOOTEN GF, COLLINS RC. Metabolic effects of unilateral lesion of the substantia nigra. J Neurosci 1981; 1: 285-291.
26. DREVETS WC, PRICE JL, SIMPSON JR, TODD RD, REICH T, VANNIER M, RAICHLE ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-827.
27. HIRAYASU Y, SHENTON ME, SAUSBURY DF, KWON JS, WIBLE CG, FISCHER IA et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999; 156:1091-1093.
28. DREVETS WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999; 877: 614-637.
29. BRODY AL, SAXENA S, SILVERMAN DHS, ALBORZIAN S, FAIRBANKS LA, PHELPS ME et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment witn paroxetine. Psychiatry Res Neuroimaging 1999; 91: 127-139.
30. KETTER T, KIMBRELL TA, LITTLE JT, GEORGE MS, SACHS N, WINSBERG ME et al. Differences and commonalties in cerebral function in bipolar compared to unipolar depression. Presentado en el: 38th Annual Meeting of the American College of Neuropsycopharmacology, Acapulco, Mexico. 1999 Diciembre.
31. BAXTER LR, PHELPS ME, MAZZIOTTA JC, GUZE BH, SCHWARTZ JM, SELIN CE. Local cerebral glucose metabolic rates in obsessivecompulsive disorder-a comparison with rates in the unipolar depression and in normal controls. Arch Gen Psychiatry 1987; 44: 211-218.
32. BIVER F, GOLDMAN S, DELVENNE V, LUXEN A, DEMAERTELAER V, HUBAIN P et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994; 36: 381-388.
33. CHOEN RM, GROSS M, NORDAHL TE, SEMPLE WE, OREN DA, ROSENTHAL N. Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 1992; 49: 545-552.
34. DREVETS WC, VIDEEN TO, PRICE JL, PRESKORN SH, CARMICHAEL ST, RAICHLE ME. A functional anatomical study of unipolar depression. J Neurosci 1992; 12: 3628-3641.
35. EBERT D, FEISTEL H, BAROCKA A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: A study with Tc-99m-HMPAO SPECT. Psychiatry Res Neuroimaging 1991; 40: 247-251.
36. MAYBERG HS, LIOTTI M, BRANNAN SK, McGINNIS BS, MAHURIN RK, JERABEK PA et al. Reciprocal limbic-cortical function and negative mood. Converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675-682.
37. NOBLER MS, SACKEIM HA, PROHOVNIK I, MOELLER JR, MUKHERJEE S, SCHNUR DB et al. Regional cerebral BF in mood disorders, III. Treatment and clinical reponse. Arch Gen Psychiatry 1994; 51: 884-897.
38. BENCH CJ, FRACKOWIAK RSJ, DOLAN RJ. Changes in the regional cerebral blood flow on recovery from depression. Psycol Med 1995; 25: 247-251.
39. DREVETS WC, SIMPSON JR, RAICHLE ME. Reciprocal suppession of regional cerebral blood flow during emotional versus higher cognitive processes: Implications for interactions between emotion and cognition. Cong Emotion 1995; 12: 353-385.
40. WU J, GILLIN C, BUCHSBAUM MS, HERSHEY T, JOHNSON JC, BUNNEY WE. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992; 149: 538-543
41. ABERCROMBIE HC, LARSON CL, WARD RT, SCHAEFER SM, HOLDEN JE, PERLMAN SB et al. Metabolic rate in amygdala predicts negative affect and depression severity in depressed patients: An FDG-PET study. Neuroimage 1996; 3: S217.
42. BAUMANN B, DANOS P, KRELL D, DIEKMANN S, LESCHINGER A, STAUCH R et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: Preliminary data from a post mortem study. J Neuropsychiatry Clin Neurosci 1999; 11: 71-78
43. KRISHNAN KRR, MCDONALD WM, ESCOLANA PR, DORAISWAMY PM, NA C, HUSAIN MM et al. Magnetic resonance imaging of the caudate nuclei in depression: Preliminary observations. Arch Gen Psychiatry 1992; 49: 553-337.
44. AWAD IA, JOHNSON PC, SPETZLER RJ, AWAD CA, CAREY R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, II: Postmortem pathological correlations. Stroke 1986; 17: 1090-1097.
45. FAZEKAS F. Magnetic resonance signal abnormalities in asymptomatic individuals: Their incidence and functional correlates. Eur Neurol 1989; 29: 164-168.
46. GRENNWALD BS, KRAMER-GINSBERG E, KRISHNAN KR, ASHTARI M, AUERBACH C, PATEL M. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geritatric depression. Stroke 1998; 29: 613-617.
47. MACFALL JR, PAYNE ME, PROVENZALE JE, KRISHNAN KR. Medial orbital frontal lesions in late-onset depression. Biol Psychiatry 2001; 49: 803-806.
48. VIDEBECH P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 1997; 97: 157-168.
49. BEARDEN CE, HOFFMAN KM, CANON TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. [Review]. Bipolar Disord 2001; 3: 106-150.
50. HARRISON PJ. The neuropathology of primary mood disorder. [Review]. Brain 2002; 125: 1428-1449.
51. AREQUE A, PARPURA V, SANZGIRI RP, HAYDON PG. Tripartite synapses: glia, the uncknowledged partner. [Review]. Trends Neurosc 1999; 22: 208-215.
52. BARRES BA. A new role for glia: generation of neurons [Review]. Cell 1999; 97: 667-670.
53. COYLE JT, SCHWARCZ R. Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry 2000; 57: 90-93.
54. BEZZI P, VOLTERRA A. A neuron-glia signalling network in the active brain. [Review]. Curr Opin Neurobiol 2001; 11: 387-394.
55. OLIET SHR, PIET R, POULAIN DA. Control of glutamate clearence and synaptic efficacy by glial coverage of neurons. Science 2001; 292: 923-926.
56. PARRI HR, GOULD TM, CRUNELLI V. Spontaneus astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation. Nat Neurosci 2001; 4: 803-812.
57. ULLIAN EM, SAPPERSTEIN S, CHRISTOPHERSON K, BARRES BA. Control of synapse number by glia. Science 2001; 291: 657-661.
58. MAGISTRETTI PJ. Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. [Review]. Brain Res 2000; 886: 108-112.
59. PORTER JT, MCCARTHY KD. Astrocytic neurotransmitter receptors in situ and in vivo. [Review]. Prog Neurobiol 1997; 51: 439-455.
60. GALLO V, GHIANI CA. Glutamate receptors in glia: new cells, new inputs and new functions. [Review]. Trends Pharmacol Sci 2000; 21: 252-258.
61. RAJKOWSKA G, HALARIS A, SELEMON LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001; 49: 741-752.
62. COTTER DR, PARIANTE CM, EVERALL IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. [Review]. Brain Res Bull 2001; 55: 585-595.
63. ROBBINS T, EVERITT B. Central norepinephrine neurons and behavior. En: Bloom F, Kupfer D, Edit. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press Ltd., 1995; 363-372.
64. RESSLER KJ, NEMEROFF CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 1999; 46: 1219-1233.
65. CLEARE A, MURRAY R, O'KEANE V. Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Psychopharmacology 1997; 134: 406-410.
66. MONGEAU R, BLIER P, DE MONTIGNY C. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Res Rev 1997; 23: 145-195.
67. VALENTINO R, FOOTE S, PAGE M. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress reponses. Ann N Y Sci 1993; 697: 171-187.
68. MAES M, MELTZER HI. The serotonine hypothesys of Major Depression. www.acnp.org.
69. DELGADO PL, CHARNEY DS, PRICE LH, LANDIS H, HENINGER GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci 1990; 45: 2323-2332.
70. HENINGER GR, DELGADO PL, CHARNEY DS, PRICE LH, AGHAJANIAN GK. Tryptophan-deficient diet and amino acid drink deplete plasma Tryptophan and induce a relapse of depression in susceptible patients. J Chem Neuroanatomy 1992; 5: 347-348.
71. ARORA RC, MELTZER HY. Increased serotonin 2(5HT-2) recpetor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 1989; 44: 725-734.
72. MIKUNI M, KAGAYA A, TAKAHASHI K, MELTZER HY. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology 1992; 106: 311-314.
73. CARPENTER W, BUNNEY W. Adrenal cortical activity in depressive ilness. Am J Psychiatry 1971: 128: 31-36.
74. MCEWEN BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000; 48: 721-731.
75. SAPOLSKY RM. The possibility of neurotoxicity in the hippocampus in Major Depresi6n: a primer on neuron death. Biol Psychiatry 2000; 48: 755-765.
76. NESTLER EJ, BARROT M, DILEONE RJ, AMELIA JE, GOLD S, MONTAGGIA LM. Neurobiology of depression. Neuron 2002; 34: 13-25.
77. ROSS EM. Signal sorting and amplification through G protein-coupled receptors. Neuron 1989; 3: 141-52.
78. DUMAN RS, NESTLER EJ. Signal transduction pathways for catecholamine receptors. www.acnmorg/G4/GN401000028/CH.html.
79. SCHREIBER G, AVISSAR S, DANON A, BELMAKER RH. Hyperfunctional G proteins in mononuclear leukocytes of patines with mania. Biol Psychiatry 1991; 29: 273-80.
80. MANJI HK, CHEN G, SHIMON H, HSIAO JK, POTTER WZ, BELMAKER RH. Guanine nucleotidebinding proteins in bipolar affective disorder. Effects of long-term lithium treatment. Arch Gen Psychiatry 1995; 52: 135-144.
81. MANJI HK, MOORE GJ, CHEN G. Bipolar Disorder: leads from the molecular and cellular mechanims of action of mood stabilisers. Br J Psychiatry 2001,178 (Suppl.41): 107-119.
82. SCOTT JD. Cyclic nucleotide-dependent protein kinases. Pharmacol Ther 1991; 50: 123-145.
83. SPAULDING SW. The ways in which hormones change cyclic adenosine 3',5'-monophosphate-dependent proteinkinases subunits, and how such changes affect cell behavior. Endocr Rev 1993; 14: 632-650.
84. FIELDS A, LI PP, KISH SJ, WARSH JJ. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with Bipolar Affective Disorder. J Neurochem 1999; 73: 1704-1710.
85. MATHEWS R, LI PP, YOUNG LT, KISH SJ, WARSH JJ. Increased G alpha q/11 inmunoreactivity in postmortem occipital cortex from patients with Bipolar Affective Disorder. Biol Psychiatry 1997; 41: 649-656.
86. SOARES JC et al. Increased platelet membrane phosphatidylinositol-4,5-biphosfate in drug free depressed bipolar patients. Neurosci Lett 2001; 299: 150-152.
87. RASMUSSEN H. The calcium messenger system. N Engl J Med 1986; 314: 1094-1101.
88. BEBCHUCK JN, ARFKEN CL, DOLAN-MANJI S, MURPHY J, HASANAT K, MANJI HK. A preliminary investigation of a proteinkinase C inhibitor in thetretment of actue mania. Arch Gen Psychiatry 2000; 57: 95-97.
89. BEZCHLIBNYK Y, YOUNG T. The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expresión. W Can J Psychiatry 2002; 47: 2.
90. DUMAN RS, MALBERG J, NAKAGAWA S, D'SA C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000; 48: 732-739.
91. GAGE FH. Structural Plasticity: cause, result, or correlate of depresi6n. Biol Psychiatry 2000; 48: 713-714.
92. ERIKSSON P, PERFILIEVA E, BJORK-ERIKSSON T, ALBORN A, NORDBORG C, PETERSON D, GAGE F. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313-1317.
93. GOULD E, REEVES A, GRAZIANO M, GROSS C. Neurogenesis in the neocortex of addult primates. Science 1999; 286: 548-552.
94. McEWEN BS, SAPOLSKY RM. Stress and cognitive function. Curr Opin Neurobiol 1995; 5: 205-216.
95. CONRAD CD, LEDOUX JE, MAGARINOS AM, McEWEN BS. Repeat restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 1999; 113: 902-913.
96. TURSKI L, TURSKI W. Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experientia 1993; 49: 1064-1072.
97. TOMBAUGH G, SAPOLSKY R. Evolving concepts about the role of acidosis in ischemic neuropathology. J Neurochem 1993; 61: 793-803.
98. SAPOLSKY R. Stress, glucocorticoids and their adverse neurological efects: revelance to aging. Exp Geront 1999; 34: 721-732.
99. MAGISTRETTI PJ, PELLERIN L, MARTIN JL. Brain energy metabolism: An integrated cellular perspective. En: Bloom FE, Kupfer DJ, Edit. Psychopharmacology: The Fourth Generatiom of Progress. New York: Raven, 1995; 921-932.
100. AZMITIA EC. Serotonin neurons, neuroplasticity, and homeostasis of neuronal tissue. Neuropsychopharmacology 1999; 21 (Suppl 2): 33S-45S.
101. MCEWEN BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999; 22: 105-122.
102. RAJKOWSKA G. Histopathology of the frontal cortex in major depression. What does it tell us about dysfunctional monoaminergic circuits? [Review]. Prog Brain Res 2000; 126: 397-412.
103. CHAPUT Y, DE MONTIGNY C, BLIER P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in rat. Neuropsychopharmacology 1991; 5: 219-229.
104. HADDJERI N, BLIER P, DE MONTIGNY C. Long-term antidepressant treatments result in tonic activation of forebrain 5-HT1A receptors. J Neurosci 1998; 18: 10150-10156.
105. MAGARINOS AM, DESLANDES A, MCEWEN BS. Effects of antidepressant and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999; 371: 113-122.
106. BROWN ES, RUSH AJ, MCEWEN BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 1999; 21: 474-484.
107. LUCASSEN PJ, MÜLLER MB, HOLSBOER F, BAUER J, HOLTROP A, WOUDA J et al. Hippocampal apoptosis in major depression is a minor event and absent fron subareas at risk for glucocorticoid overexposure. Am J Pathol 2001; 49: 803-806.
108. MÜLLER MB, LUCASSEN PJ, YASSOURIDIS A, HOOGENDIJK WJG, HOLSBOER F, SWAAB DF. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001; 1063-1612.
109. ONGÜR D, DREVETS WC, PRICE JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
110. BENES FM, VINCENT SL, TODTENKOPF M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjetcs. Biol Psiquiatry 2001; 50: 395-404.
111. RAJKOWSKA G, MIGUEL-HIDALGO JJ, WEI J, DILLEY G, PITTMAN SD, MELTZER HY et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085q-1098.
112. MIGUEL-HIDALGO JJ, BAUCOM C, DILLEY G, OVERHOLSER JC, MELTZRE HY, STOCKMEIER CA et al. Glial fibrillary acidic protein inmunoreactivity in the prefrontal cortex distinguises younger from older adults in major depressive disorder. Biol Psychiatry 2000; 48: 861-873.
113. ROSOKLIJA G, TOOMAYAU G, ELLIS SP, KEILP A, MANN JJ, LATOV N. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: Preliminary findings. Arch Gen Psychiatry 2000; 57: 349-356.
114. ZHOU JN, RIEMESMA RF, UNMEHOPA VA, HOODENDIJK WJ, VAN HEERIKHUIZE JJ. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry 2001; 58: 655-662.
115. BAUMANN B, DANOS P, DIEKMANN S, KRELL D, BIELAU H, GERETSEGGER C. Tyrosine hidroxilase inmunoreactivity in the locus coeruleus is reduced in depression. Eur Arch Psychiatry Clin Neurosci 1999; 249: 212-219.